Epidermal Growth Factor Receptor Family Inhibition Identifies P38 Mitogen-activated Protein Kinase as a Potential Therapeutic Target in Bladder Cancer. [electronic resource]
Producer: 20181211Description: 225.e1-225.e7 p. digitalISSN:- 1527-9995
- Antineoplastic Agents -- therapeutic use
- Cell Line, Tumor
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride -- therapeutic use
- Humans
- Lapatinib -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Receptor, ErbB-2 -- antagonists & inhibitors
- Signal Transduction
- Urinary Bladder Neoplasms -- drug therapy
- p38 Mitogen-Activated Protein Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.